Sedeighzadeh, S. S., Galehdari, H., Tabandeh, M. R., Shamsara, M., & Roohbakhsh, A. The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors. Wiley.
Chicago Style (17th ed.) CitationSedeighzadeh, Sahar Sadat, Hamid Galehdari, Mohammad Reza Tabandeh, Mehdi Shamsara, and Ali Roohbakhsh. The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors. Wiley.
MLA (9th ed.) CitationSedeighzadeh, Sahar Sadat, et al. The Endocannabinoid, Anandamide, Acts as a Novel Inhibitor of LPS-Induced Inflammasome Activation in Human Gastric Cancer AGS Cell Line: Involvement of CB1 and TRPV1 Receptors. Wiley.